Effects of Manufacturing Process Variables on the Tablet Weight Variation of Mini-tablets Clarified by a Definitive Screening Design.

definitive screening design fluidized bed granulator granule property mini-tablet tablet weight variation wet granulation

Journal

Chemical & pharmaceutical bulletin
ISSN: 1347-5223
Titre abrégé: Chem Pharm Bull (Tokyo)
Pays: Japan
ID NLM: 0377775

Informations de publication

Date de publication:
2021
Historique:
entrez: 2 9 2021
pubmed: 3 9 2021
medline: 13 10 2021
Statut: ppublish

Résumé

This study investigated the effect of manufacturing process variables of mini-tablets, in particular, the effect of process variables concerning fluidized bed granulation on tablet weight variation. Test granules were produced with different granulation conditions according to a definitive screening design (DSD). The five evaluated factors assigned to DSD were: the grinding speed of the sample mill at the grinding process of the active pharmaceutical ingredient (X1), microcrystalline cellulose content in granules (X2), inlet air temperature (X3), binder concentration (X4) and the spray speed of the binder solution (X5) at the granulation process. First, the relationships between the evaluated factors and the granule properties were investigated. As a result of the DSD analysis, the mode of action of granulation parameters on the granule properties was fully characterized. Subsequently, the variation in tablet weight was examined. In addition to mini-tablets (3 mm diameter), this experiment assessed regular tablets (8 mm diameter). From the results for regular tablets, the variation in tablet weight was affected by the flowability of granules. By contrast, regarding the mini-tablets, no significant effect on the variation of tablet weight was found from the evaluated factors. From this result, this study further focused on other important factors besides the granulation process, and then the effect of the die-hole position of the multiple-tip tooling on tablet weight variation was proven to be significant. Our findings provide a better understanding of manufacturing mini-tablets.

Identifiants

pubmed: 34470954
doi: 10.1248/cpb.c21-00427
doi:

Substances chimiques

Tablets 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

896-904

Auteurs

Shui Usuda (S)

Laboratory of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama.

Naohiro Masukawa (N)

JMP Japan, SAS Institute Japan Ltd.

Kok Hoong Leong (KH)

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Malaya.

Kotaro Okada (K)

Laboratory of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama.

Yoshinori Onuki (Y)

Laboratory of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama.

Articles similaires

Alzheimer Disease Humans Regression Analysis Quantitative Structure-Activity Relationship Drug Design
Humans Chondrocytes Osteoarthritis Matrix Metalloproteinase 13 Drug Discovery
Nanoparticles Needles Polylactic Acid-Polyglycolic Acid Copolymer Polyethylene Glycols Curcumin
Glycoside Hydrolase Inhibitors Quantitative Structure-Activity Relationship Molecular Docking Simulation alpha-Glucosidases Molecular Dynamics Simulation

Classifications MeSH